Immunopathogenesis of multiple sclerosis

被引:37
作者
Agrawal, Smriti M. [1 ]
Yong, V. Wee
机构
[1] Univ Calgary, Dept Clin Neurosci, Calgary, AB T2N 4N1, Canada
[2] Univ Calgary, Dept Oncol, Calgary, AB T2N 4N1, Canada
来源
NEUROBIOLOGY OF MULTIPLE SCLEROSIS | 2007年 / 79卷
关键词
D O I
10.1016/S0074-7742(07)79005-0
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Multiple sclerosis (MS) is considered an immune-mediated disorder in which immune cells cross the blood-brain barrier to enter the central nervous system (CNS) wherein they augment the neuropathology of the disease. This chapter discusses the role of various immune cell types that contribute to the development and progression of MS. Specifically, the role of T cells, antigen-presenting cells, and components of the innate immune system such as macrophages, B cells, and the complement system are discussed. The involvement of CNS-specific cells such as microglia, astrocytes, and neurons in MS are discussed and the immunosuppressive role of regulatory T cells is considered. We introduce the involvement of chemokines and matrix metalloproteinases which helps recruit immune cells into the CNS in MS. Although the causes of MS are unknown, various factors such as genetic influences, environmental effects, and involvement of infectious agents as potential contributors to MS immune dysfunctions are also considered. With this background, we discuss the mechanisms of the immunomodulators that are used to treat MS.
引用
收藏
页码:99 / +
页数:31
相关论文
共 144 条
[1]   Dystroglycan is selectively cleaved at the parenchymal basement membrane at sites of leukocyte extravasation in experimental autoimmune encephalomyelitis [J].
Agrawal, S ;
Anderson, P ;
Durbeej, M ;
van Rooijen, N ;
Ivars, F ;
Opdenakker, G ;
Sorokin, LM .
JOURNAL OF EXPERIMENTAL MEDICINE, 2006, 203 (04) :1007-1019
[2]   Specific Th2 cells accumulate in the central nervous system of mice protected against experimental autoimmune encephalomyelitis by copolymer 1 [J].
Aharoni, R ;
Teitelbaum, D ;
Leitner, O ;
Meshorer, A ;
Sela, M ;
Arnon, R .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2000, 97 (21) :11472-11477
[3]  
Alt C, 2002, EUR J IMMUNOL, V32, P2133, DOI 10.1002/1521-4141(200208)32:8<2133::AID-IMMU2133>3.0.CO
[4]  
2-W
[5]   New insights into the mechanism of action of copolymer 1 in experimental allergic encephalomyelitis and multiple sclerosis [J].
Arnon, R ;
Sela, M ;
Teitelbaum, D .
JOURNAL OF NEUROLOGY, 1996, 243 (04) :S8-S13
[6]  
Babcock A, 2003, ADV EXP MED BIOL, V520, P120
[7]   Human regulatory T cells and their role in autoimmune disease [J].
Baecher-Allan, Clare ;
Hafler, David A. .
IMMUNOLOGICAL REVIEWS, 2006, 212 :203-216
[8]   Immunology of multiple sclerosis [J].
Bar-Or, A .
NEUROLOGIC CLINICS, 2005, 23 (01) :149-+
[9]   Analyses of all matrix metalloproteinase members in leukocytes emphasize monocytes as major inflammatory mediators in multiple sclerosis [J].
Bar-Or, A ;
Nuttall, RK ;
Duddy, M ;
Alter, A ;
Kim, HJ ;
Ifergan, I ;
Pennington, CJ ;
Bourgoin, P ;
Edwards, DR ;
Yong, VW .
BRAIN, 2003, 126 :2738-2749
[10]  
Baranzini SE, 1999, J IMMUNOL, V163, P5133